Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

News Trending Portfolio

TOOLS

Top Smart Score Stocks

STOCKS

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

FibroGen (FGEN)

NASDAQ:FGEN

FGEN

FibroGen

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding FGEN?

Track your performance easily

Link Broker

FibroGen (FGEN) Stock News & Sentiment

926 Followers

FGEN Upcoming Earnings Report: What to Expect?

Premium

Pre-Earnings

FGEN Upcoming Earnings Report: What to Expect?

28d ago

FGEN

FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate Update

Premium

Press Releases

FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate Update

1M ago

FGEN

FibroGen to Report Second Quarter 2024 Financial Results

Premium

Press Releases

FibroGen to Report Second Quarter 2024 Financial Results

1M ago

FGEN

FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024

Premium

Press Releases

FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program in Metastatic Castration-Resistant Prostate Cancer on June 26, 2024

2M ago

FGEN

FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen’s Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination with LIBTAYO® in Upcoming Clinical Trials

Premium

Press Releases

FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroGen’s Immuno-Oncology Assets, FG-3165 (anti-Galectin 9) and FG-3175 (anti-CCR8), in Combination with LIBTAYO® in Upcoming Clinical Trials

3M ago

FGEN

FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors

Premium

Press Releases

FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 Targeting Monoclonal Antibody, for the Treatment of Patients with Solid Tumors

3M ago

FGEN

FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) at the 2024 American Society of Clinical Oncology Annual Meeting

Premium

Press Releases

FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC) at the 2024 American Society of Clinical Oncology Annual Meeting

3M ago

FGEN

More FGEN News >

FGEN News on the Web

2024-08-09

FibroGen, Inc. Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates

Yahoo Finance

Neutral

2024-08-07

FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q2 2024

InvestorPlace

Neutral

2024-08-06

FibroGen Reports Q2 Loss, Tops Revenue Estimates

Yahoo Finance

Neutral

2024-08-06

FibroGen (FGEN) Reports Q2 Loss, Tops Revenue Estimates

Zacks

Neutral

2024-08-06

FibroGen: Q2 Earnings Snapshot

Yahoo Finance

Neutral

2024-08-06

FibroGen Reports Second Quarter 2024 Financial Results and Provides Business Update

Yahoo Finance

Neutral

2024-08-04

Weekly Biotech Buzz: FGEN Cuts Jobs, FDA OKs ADAP's Groundbreaking Cell Therapy, ME Rebuffs CEO Bid

rttnews

Neutral

2024-07-31

FibroGen axes 75% of staff after lead cancer therapy fails in Phase III trials

Pharmaceutical Technology

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FGEN’s Media Buzz Sentiment?

Currently, no data Available

What is FGEN’s weekly average amount of articles?

Currently, no data Available

What is FGEN’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

COOCooper Co

BIOBiome Australia Ltd

CSXCleanSpace Holdings Ltd.

VEEVVeeva Systems

JUMPLeveljump Healthcare Corp.

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing